Across TCGA pan-cancer cohorts, RNU6-355P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-355P data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RNU6-355P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-355P expression acts as an unfavorable survival marker.

CESC, LUAD, and COAD are the cancer types where RNU6-355P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	All	0.092	0.590	<.001	72	view →
LUAD	OS	Tertile	All	0.266	0.835	.002	54	view →
COAD	OS	Tertile	All	0.181	0.806	.002	36	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU6-355P tumor-vs-normal RNA expression · all RNU6-355P data types